进入第三级护理中心重症监护病房的成年人感染败血症
Kundu Shrestha1, Sagun Ram Vaidya2, Keny Shrestha3
1Department of Anesthesiology and Critical Care, Nepal Armed Police Force Hospital, Balambu, Kathmandu, Nepal.
JNMA; journal of the Nepal Medical Association
|February 27, 2024
概括
败血症影响了尼泊尔近38%的成人重症监护病房患者,比国际上报告的更高的患病率. 了解败血症患病率对于改善低收入环境中的重症监护结果至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 传染病 流行病学 流行病学
背景情况:
- 败血症是一个危及生命的全球健康问题,特别是在重症患者中.
- 虽然高收入国家记录了败血症流行病学,但尼泊尔等低收入和中等收入国家的数据很少.
- 这项研究解决了关于尼泊尔重症监护病房中败血症患病率的知识差距.
研究的目的:
- 为了确定进入尼泊尔第三级护理中心重症监护病房的成年患者中败血症的患病率.
- 提供必要的流行病学数据,在低资源环境下对败血症.
主要方法:
- 进行了一项描述性的横截面研究.
- 数据是从2022年1月11日至2022年12月29日期间的成人重症监护室患者记录中收集的.
- 采用了方便抽样方法,使用95%置信区间计算了患病率.
主要成果:
- 该研究包括195名成年患者,败血症的患病率为37.95% (95%CI:31.14-44.76).
- 败血症患者的平均年龄为44岁,54.05%是男性.
- 在败血症患者中,37.84%有两种或更多的诊断,12.16%有两种或更多的并发症.
结论:
- 在尼泊尔的重症监护室中,败血症的患病率明显高于许多国际研究中观察到的.
- 这些发现凸显了低收入国家中重症监护机构中败血症的重大负担.
- 进一步的研究和有针对性的干预措施是有必要的,以解决尼泊尔的败血症.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K
Pneumonia I: Introduction
238
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
Asepsis
2.1K
The condition of being free from disease-causing living pathogens is asepsis. Aseptic techniques include a set of standard practices to achieve asepsis. An example is the regular environmental cleaning of all parts of the healthcare facility and hand hygiene at home before preparing or eating food. Medical and surgical asepsis in healthcare practice protects patients from harmful pathogens, minimizes the risk of contamination of susceptible sites, and reduces the risk of infection transmission.
2.1K
Pneumonia III: Complications and Assessment
215
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
215
Pneumonia IV: Management
327
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327


